These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Synthesis and evaluation of bivalent ligands for binding to the human melanocortin-4 receptor. Fernandes SM; Lee YS; Gillies RJ; Hruby VJ Bioorg Med Chem; 2014 Nov; 22(22):6360-5. PubMed ID: 25438759 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of bivalent NDP-alpha-MSH(7) peptide ligands for binding to the human melanocortin receptor 4 (hMC4R). Handl HL; Sankaranarayanan R; Josan JS; Vagner J; Mash EA; Gillies RJ; Hruby VJ Bioconjug Chem; 2007; 18(4):1101-9. PubMed ID: 17591746 [TBL] [Abstract][Full Text] [Related]
12. Heterobivalent ligands crosslink multiple cell-surface receptors: the human melanocortin-4 and delta-opioid receptors. Vagner J; Xu L; Handl HL; Josan JS; Morse DL; Mash EA; Gillies RJ; Hruby VJ Angew Chem Int Ed Engl; 2008; 47(9):1685-8. PubMed ID: 18205159 [No Abstract] [Full Text] [Related]
13. Modular One-Pot Strategy for the Synthesis of Heterobivalent Tracers. Bailly T; Bodin S; Goncalves V; Denat F; Morgat C; Prignon A; Valverde IE ACS Med Chem Lett; 2023 May; 14(5):636-644. PubMed ID: 37197474 [TBL] [Abstract][Full Text] [Related]
14. Two for the Price of One: Heterobivalent Ligand Design Targeting Two Binding Sites on Voltage-Gated Sodium Channels Slows Ligand Dissociation and Enhances Potency. Peschel A; Cardoso FC; Walker AA; Durek T; Stone MRL; Braga Emidio N; Dawson PE; Muttenthaler M; King GF J Med Chem; 2020 Nov; 63(21):12773-12785. PubMed ID: 33078946 [TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of trivalent ligands targeting opioid, cholecystokinin, and melanocortin receptors for the treatment of pain. Lee YS; Fernandes S; Kulkarani V; Mayorov A; Davis P; Ma SW; Brown K; Gillies RJ; Lai J; Porreca F; Hruby VJ Bioorg Med Chem Lett; 2010 Jul; 20(14):4080-4. PubMed ID: 20547453 [TBL] [Abstract][Full Text] [Related]
16. Thermodynamics of multivalent interactions: influence of the linker. Kane RS Langmuir; 2010 Jun; 26(11):8636-40. PubMed ID: 20131760 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of new cyclic melanotropin peptide analogues selective for the human melanocortin-4 receptor. Ying J; Gu X; Cai M; Dedek M; Vagner J; Trivedi DB; Hruby VJ J Med Chem; 2006 Nov; 49(23):6888-96. PubMed ID: 17154518 [TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, and Pharmacological Characterization of Heterobivalent Ligands for the Putative 5-HT Poulie CBM; Liu N; Jensen AA; Bunch L J Med Chem; 2020 Sep; 63(17):9928-9949. PubMed ID: 32815361 [TBL] [Abstract][Full Text] [Related]
19. Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy. Judmann B; Braun D; Wängler B; Schirrmacher R; Fricker G; Wängler C Pharmaceuticals (Basel); 2020 Jul; 13(8):. PubMed ID: 32751666 [TBL] [Abstract][Full Text] [Related]
20. Radiolabeling approaches for cholecystokinin B receptor imaging. Aloj L; Panico MR; Caracó C; Zannetti A; Del Vecchio S; Di Nuzzo C; Arra C; Morelli G; Tesauro D; De Luca S; Pedone C; Salvatore M Biopolymers; 2002; 66(6):370-80. PubMed ID: 12658724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]